Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest
1 other identifier
interventional
80
1 country
3
Brief Summary
The presence of certain ingredients such as sodium and glycerol can facilitate retention of the fluid consumed via renal water reabsorption. To maintain overall whole-body fluid balance, it is important that ingested fluid is retained in the body instead of losing it through urination. The purpose of this study is to determine the effect of sodium and glycerol concentrations at various fluid intake volumes on fluid balance in healthy, euhydrated men and women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedStudy Start
First participant enrolled
April 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJuly 17, 2025
July 1, 2025
8 months
February 19, 2025
July 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fluid balance
Calculated as change in body mass kg and %
Change from baseline (pre-beverage) to post-beverage Time 30, 60, 90,120, 150,180 and 210 minutes
Secondary Outcomes (17)
Urine mass
Change from baseline (pre-beverage) to post-beverage Time 30, 60, 90,120, 150,180 and 210 minutes
Urine specific gravity
Change from baseline (pre-beverage) to post-beverage Time 30, 60, 90,120, 150,180 and 210 minutes
Urine osmolality
Change from baseline (pre-beverage) to post-beverage Time 30, 60, 90,120, 150,180 and 210 minutes
Whole blood hematocrit
Change from baseline (pre-beverage) to post-beverage Time 30, 90,150 and 210 minutes
Whole blood hemoglobin concentration
Change from baseline (pre-beverage) to post-beverage Time 30, 90,150 and 210 minutes
- +12 more secondary outcomes
Study Arms (10)
Placebo beverage
PLACEBO COMPARATORBase beverage, no electrolytes, no glycerol
Electrolyte solution without glycerol beverage 1
EXPERIMENTALHigher electrolytes lower volume
Electrolyte solution without glycerol beverage 2
EXPERIMENTALLower electrolytes mid-volume
Electrolyte solution without glycerol beverage 3
EXPERIMENTALHigher electrolytes higher volume
Electrolyte solution with glycerol beverage 1
EXPERIMENTALLower electrolytes, lower glycerol, lower volume
Electrolyte solution with glycerol beverage 2
EXPERIMENTALHigher electrolytes, higher glycerol, lower volume
Electrolyte solution with glycerol beverage 3
EXPERIMENTALHigher electrolytes, higher glycerol, higher volume
Base with glycerol beverage 1
EXPERIMENTALNo electrolytes, higher glycerol, lower volume
Base with glycerol beverage 2
EXPERIMENTALNo electrolytes, lower glycerol, mid-volume
Base with glycerol beverage 3
EXPERIMENTALNo electrolytes, higher glycerol, higher volume
Interventions
9.3.oz 3 times for a total of 28 oz over a 35 min period followed by 25 min rest until Time 0 post-dose
4 oz 3 times for a total of 12 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
6.7 oz 3 times for a total of 20 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
9.3.oz 3 times for a total of 28 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
4 oz 3 times for a total of 12 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
4 oz 3 times for a total of 12 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
9.3.oz 3 times for a total of 28 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
4 oz 3 times for a total of 12 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
6.7 oz 3 times for a total of 20 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
9.3.oz 3 times for a total of 28 oz over a 35 min period followed by 25 min rest until Time 0 post-dose. Beverage matched to placebo for color and flavor.
Eligibility Criteria
You may qualify if:
- Subject is male or female
- If female, subject is not pregnant
- Subject is 18-50 years of age, inclusive
- Subject is at least recreationally active (engaged in light to moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 30 min at a time)
- Subject does not smoke (or has quit for at least 6 months)
- Subject is not taking medication that may interfere with the study (e.g., diuretics)
- Subject has no health conditions that would interfere with the study (e.g. cardiovascular, renal, or metabolic diseases)
- Subject is willing to avoid alcohol consumption 24 hours prior to visit(s)
- Subject is willing to fast overnight (\~8-12 hours)
- Subject is willing to refrain from vigorous exercise for 24 hours
- Subject is willing to eat the exact same food the day prior to each visit to the laboratory
- Provision of written consent to participate
You may not qualify if:
- Subject has participated in a clinical trial within the past 30 days
- Subject has participated in any PepsiCo trial within past 6 months
- Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results, or put the person at undue risk
- Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be considered a competitor to Gatorade, they will be asked to please let the study investigator know the name of the other company and the nature of their relationship to that company before they sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
IMG Academy/GSSI Bradenton Gatorade Sports Science Institute
Bradenton, Florida, 34210, United States
GCP Research
St. Petersburg, Florida, 33705, United States
Gatorade Sports Science Institute
Valhalla, New York, 10595, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lindsay Baker, PhD
PepsiCo R&D/Gatorade and Sports Science Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2025
First Posted
March 3, 2025
Study Start
April 9, 2025
Primary Completion
December 15, 2025
Study Completion
December 15, 2025
Last Updated
July 17, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share